Aug 2026· The Journal of Applied Laboratory Medicine· Vol 11, pp. 1406-1418· 0 citations
Medicine
TL;DR
The results demonstrated that the TriageTrue hs-cTnI whole blood test could serve as an alternative method for ruling out or confirming non-ST-elevation myocardial infarction in the prehospital setting using a single POC troponin measurement.
Abstract
Background
Point-of-care (POC) testing and triage liaison physicians could help alleviate the impact of emergency department (ED) overcrowding. The aim of our study was to evaluate the diagnostic performance of the TriageTrue POC assay for the rapid rule-out of myocardial infarction based on a single measurement of high-sensitivity cardiac troponin I (hs-CTnI). The diagnostic performance was compared to measurements obtained with the Vitros 3600 assay, taking into account the cutoffs recommended by the European Society of Cardiology.
Methods
The study compared results of troponin obtained simultaneously on the TriageMeterPro device from whole blood and plasma samples (n = 139) and the hs-cTnI assay on the Vitros 3600 instrument from EDTA plasma samples (n = 225). The diagnostic performance of the 3 methods was compared, including negative predictive value and sensitivity as well as positive predictive value and specificity. Concordance between the methods with disease state samples was then assessed using the Cohen kappa test.
Results
An excellent correlation between plasma and whole blood samples was achieved with the TriageTrue with a coefficient of correlation >0.99 and a bias of +8.2 (±45, with 95% CI 0.4 to 16.0) ng/L. A significant overestimation (around 47%) of the values obtained with the TriageTrue compared with those of the Vitros was also observed. Our results confirmed the acceptable and comparable diagnostic accuracy to the established hs-cTnI-Vitros assay, with a negative predictive value of 100% to rule-out myocardial infarction.
Conclusion
Our results demonstrated that the TriageTrue hs-cTnI whole blood test could serve as an alternative method for ruling out or confirming non-ST-elevation myocardial infarction in the prehospital setting using a single POC troponin measurement.
The Abbott i-STAT Alinity POCT hs-cTnI assay demonstrated analytical performance and clinical concordance supportive of local implementation, with similar diagnostic discrimination to the Alinity laboratory hs-cTnI assay in a small cohort.
A. Burns, Vaishnavi Muthukrishnan, U. Razzaq et al.· Annals of Clinical Biochemis...· 0 citations
The European Society of Cardiology (ESC) 0/1-hour algorithm is recommended for the rapid triage of patients with suspected non-ST-elevation myocardial infarction (NSTEMI). While this strategy is well-established for the reference high-sensitivity cardiac troponin T (hs-cTnT) assay, the algorithm is assay-dependen...
A. Nguyen, D. U. N. G. Dao, T. Phạm et al.· European Heart Journal· 0 citations
High-sensitivity cardiac troponin (hs-cTn) assays have significantly enhanced the diagnosis in patients suspected of acute coronary syndrome (ACS). New hs-cTn point-of-care (POC) devices (turnaround time <20 min) may significantly reduce time to diagnosis. We evaluated the diagnostic accuracy of four currently commerci...
L. E. van Daalen, B. Schueler, P. Collinson et al.· European journal of emergenc...· 0 citations
BACKGROUND
High-sensitivity cardiac troponin (hs-cTn) discerns MI with high sensitivity, facilitating swift ED discharge. Yet, its application in Chinese cohorts is understudied. This study seeks optimal hs-cTnI and hs-cTnT thresholds for low-risk patient identification in Chinese EDs, utilizing Abbott and Roche assays...
Fang-Fang Yang, Ya-Hui Lin, Hong Zhan et al.· Clinica chimica acta; intern...· 0 citations
High-sensitivity cardiac troponin (hs-cTn) assays have enabled safe early discharge of patients at very low risk for myocardial infarction. We previously developed a single-sample rule out pathway using the ARCHITECT hs-cTnI assay and showed that it was safe and effective when implemented in practice. In a second...
R. Wereski, Z. Li, T. Fujisawa et al.· European Heart Journal· 0 citations
OBJECTIVE
Although point-of-care (POC) high-sensitivity cardiac troponin I (hs-cTnI) assays have demonstrated good analytical agreement with central laboratory (CL) testing, it remains uncertain whether they yield the same clinical triage decisions. We evaluated the clinical concordance of a POC hs-cTnI assay with a CL...
N. Kongruttanachok, Naphat Chaijirawiwat, M. T. Angkana Chirapanuruk et al.· Clinica chimica acta; intern...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.